Month: March 2025

The ARC-IM Lumbar Lead is the second model in the ARC-IM Lead family to be used in a clinical feasibility study The Company is building a portfolio of purpose-designed leads to optimize delivery of ARC-IM Therapy at various locations along the spinal cord to enable restoration of movement and other functions EINDHOVEN, the Netherlands, March 26, 2025 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announces the first human implant of its investigational ARC-IM® Lumbar Lead. This milestone procedure was performed on March 17, 2025, by Dr. Jocelyne Bloch, Chief of Neurosurgery at Lausanne University Hospital (CHUV)...

Closing of the sale of the FPSO BW Pioneer Reference is made to the announcement dated 12 March 2025, in which BW Offshore Limited (“BW Offshore”) announced its agreement to sell the FPSO BW Pioneer for USD 125 million to a subsidiary of Murphy Oil Corporation (NYSE: MUR). Following the close of the transaction, BW Offshore has received the initial payment of USD 100 million. The remaining balance is expected before end of Q2 2025 when certain contractual obligations are met. The two parties have also signed a five-year reimbursable O&M contract, under which BW Offshore will continue to provide operations and maintenance services. For further information, please contact:Ståle Andreassen, CFO, +47 91 71 86 55 IR@bwoffshore.com or www.bwoffshore.com About BW Offshore:BW Offshore engineers innovative floating production solutions. The...

Chlamydia vaccine candidate granted fast track designation by the US FDAChlamydia infection can contribute to pelvic inflammatory diseases in women, which can lead to pregnancy complications or infertility A phase 1/2 clinical study evaluating the immunogenicity and safety of the vaccine candidate is due to start in coming daysParis, March 26, 2025. The US Food and Drug Administration has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection. The decision was based on the potential of the vaccine candidate to address a serious condition and address an unmet public health need. The chlamydia vaccine candidate has been designed to protect against primary genital tract infection and reinfection by the bacterium Chlamydia trachomatis. Following a promising pre-clinical program, Sanofi...

Facephi Leads NIST Ranking, Outperforming Top Biometric Technology Providers in Accuracy and EfficiencyFacephi’s latest Software Development Kit (SDK) has achieved a significant boost in precision, securing a leading position in NIST’s global ranking. Its biometric engine ensures a security threshold of 1 in a 1,000,000, drastically reducing the risk of identity fraud. The technology excels in challenging conditions, including aging detection and facial recognition at extreme angles.Alicante, March 26th, 2025 – Facephi Biometría, SA (BME Growth: FACE; Euronext Growth Paris: ALPHI) (“Facephi” or the “Company”), a Spanish tech leader in global digital identity protection and verification, announces that it has secured a top position in the latest NIST ranking, surpassing major biometric technology providers and reinforcing its...

26 March 2025 PRESS RELEASE Ad hoc announcement pursuant to Art. 53 Listing Rules: GAM announces 2024 full year results Strong progress in implementing turnaround strategy. GAM continues to target profitability in fiscal year 2026. Financial Highlights for Full Year 2024IFRS net loss of CHF 70.9 million compared to CHF 82.1 million for FY 2023. Underlying loss before tax of CHF 66.8 million compared to CHF 49.5 million for FY 2023. AuM at CHF 16.3 billion compared to CHF 19.3 billion as at 31 December 2023. Cost optimisation initiatives across the business resulted in a 20% decrease in underlying expenses compared to FY 2023. The full impact of these cost optimisation initiatives will be reflected in FY 2025 and beyond. Successful CHF 100 million rights issue completed in November 2024, which resulted in our anchor shareholder, NJJ Holding...

Mowi has today published its 2024 Integrated Annual Report, including sustainability reporting and complete 2024 annual accounts with notes. The integrated report is attached, available in European Single Electronic Format (ESEF) and has been published on www.mowi.com/investors/reports/ The Green Financing Impact Report in relation to Mowi’s Green Bond issuance has also been published today and is available on our website www.mowi.com/investors/share-and-bond/bonds/ This information is subject to the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.         AttachmentsMowi Integrated Annual Report 2024mowi-2024-12-31-en

VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) — Walker Lane Resources Ltd. (TSX-V: WLR, “Walker Lane”) announces that it has optioned three properties (i.e., Tule Canyon, Cambridge and Silver Mountain – see location map Figure 1) located in the Walker Lane of western Nevada and a right-of-first refusal on the Shamrock Property in eastern Nevada from Silver Range Resources Ltd. (“Silver Range”) (TSX-V:SNG). The original property agreements were signed with the CMC Metals Ltd. now operating as Walker Lane Resources Ltd. and trading under the symbol “WLR” on the TSX Venture Exchange. Walker Lane has established a solid position in the Walker Lane Gold Trend Area which has a rich history of mining and exploration and remains vastly underexposed to modern exploration methods, offering substantial upside potential. The...

TORONTO, March 25, 2025 (GLOBE NEWSWIRE) — Firm Capital Property Trust (“FCPT” or the “Trust”) (TSX : FCD.UN) is pleased to announce that its Montreal Industrial Portfolio Joint Venture (“Montreal Industrial JV”) has entered into a binding agreement to sell a 100% interest in a single tenant, 159,470 square foot industrial facility for gross proceeds of approximately $27.9 million ($27.5 million net of closing costs). The Trust’s portion of the gross proceeds after closing costs are approximately $13.8 million. Closing is anticipated to be during the second quarter of 2025. PROPERTY DETAILSThe property has been owned by the Trust in the 50/50 Montreal Industrial JV since 2018 and was originally purchased for $11.0 million (at 100% ownership). The property is currently carried on the Trust’s balance sheet at an IFRS value of approximately...